Dvora Teitelbaum

Prof. Michael Sela

Copaxone® - MS medication

10.10.2010

Benefiting Humanity, Diagnostic Techniques and Drugs

from the institute to Teva Pharmaceuticals Ltd.

Genes that affect reponses of MS to Copaxone

Genes that affect reponses of MS to Copaxone

10.10.2007

Disease, Drugs & Diagnostics

Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®

...

Cop 1 (Copaxone®): The Story of a Drug

Cop 1 (Copaxone®): The Story of a Drug

01.05.1997

Disease, Drugs & Diagnostics

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

Prof. Ruth Arnon

'Women of Distinction' Award to Two Weizmann Institute Scientists

28.01.1997

REHOVOT, Israel -- January 28, 1997 -- This week, two scientists from Israel's Weizmann Institute were honored for an...

Top Stories

Uncrackable: Scorpions and Sponges Inspire Sustainable Design

Hunting Down Giant Viruses That Attack Tiny Algae

Couples Therapy

Couples Therapy

Crystals in zebrafish eye

A Secret Recipe for Colorful and Versatile Animal Crystals

Press Releases

The Weizmann Institute of Science Ranked among the World’s Top Ten Academic Institutions

A Discovery to Set Your Heart a-Knocking

Navigating the Digestive Tract

Most Popular Articles

The Limits of Computing

Computers can solve complex problems but they are far from omnipotent. Prof. Ran Raz of the Weizmann Institute's Computer Science and Applied Mathematics Department is trying to portray the limits...

Prof. Zvi Artstein, Vice President for Technology Transfer

Prof. Zvi Artstein

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.